Session Abstract – PMWC 2027 Silicon Valley
The PMWC 2027 AI Company Showcase will provide a 15-30 minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.
Confirmed Presenting Companies:
Speaker Profile
Founder & CEO, Onymos
Biography
Shiva Nathan is the founder of Onymos, a Silicon Valley-based software company building intelligent automation solutions for healthcare and life sciences. Before founding Onymos, Shiva was Head of Intuit's Platforms Services organization. He has also held technical leadership positions at Oracle and CA. These companies continue to leverage the products he helped define and build. He is an alumnus of BITS Pilani and UC Berkeleys Haas School of Business.
AI and Data Sciences Showcase:
Onymos
Onymos is building innovative automation software for the high-trust, high-stakes environments inside healthcare and life sciences. It helps organizations modernize their workflows and unlock the value of unstructured data without ever compromising security, compliance, or control.
Speaker Profile
CEO, Nimblemind
Biography
Pi is a tech veteran, having spent the last 10 years leading technical teams at Accenture, AWS, and Stripe. At AWS, he helped launch over 40 first-party services, including AWS Data Marketplace. Pi led the first epic deployment on AWS and the first Alexa deployment in a healthcare setting.
Talk
NimbleLabs: The Agentic OS for Better Healthcare
Healthcare has a problem: clinical data is too fragmented and unstructured for AI reasoning, forcing organizations to spend months cleaning, labeling, and harmonizing data. This is where NimbleLabs comes in: our Nimblemind multi-agent system automates data preparation, transforming multi-modal information into analysis-ready datasets.
AI and Data Sciences Showcase:
Nimblemind
Nimblemind is addressing one of healthcare AI's biggest bottlenecks: preparing usable clinical data. Our approach uses specialty-specific AI agents to transform fragmented multimodal clinical data into structured datasets.
Speaker Profile
Senior NGS Services Manager, Zymo Research
Biography
Emily Chen is a life sciences professional with over 10 years of experience in NGS service operations. She has led projects across the full workflow—from sample processing to final data delivery—supporting high-throughput NGS applications with a strong focus on quality, efficiency, and collaboration. By optimizing laboratory processes, implementing automation, and streamlining project tracking systems, Emily strives to transform complex and variable biological samples into reliable, actionable data. Her work directly enables genome-, epigenome-, and transcriptome-focused analyses to overcome technical and analytical challenges in molecular diagnostics, improving assay robustness, turnaround time, and data confidence to support accurate decision-making in research and clinical settings.
Talk
AI and Data Sciences Showcase:
Zymo Research
Zymo Research, a privately owned biotech company founded in 1994, is a global leader in molecular tools for life sciences. Driven by the principle "The Beauty of Science is to Make Things Simple," Zymo is dedicated to developing innovative solutions that address complex scientific challenges.
Speaker Profile
M.D., CMO, Medlink Global
Biography
Christoph Correll, M.D., is Chief Medical Officer of MedLink Global and a Professor of Psychiatry at the Zucker School of Medicine at Hofstra/Northwell, with an additional professorship in child and adolescent psychiatry at Charité University Medicine Berlin. He is a clinician-researcher whose work focuses on severe mental illness across the lifespan, particularly schizophrenia, bipolar disorder, and related conditions. His research spans clinical trials, comparative effectiveness, psychopharmacology, meta-analysis, epidemiology, and the interaction between psychiatric illness, treatment, and physical health. Dr. Correll has published extensively on treatment selection, early intervention, adverse effects, cardiometabolic risk, and strategies to improve long-term outcomes for people receiving antipsychotic and other psychiatric medications. He completed medical studies in Berlin and Dundee and trained in both general psychiatry and child and adolescent psychiatry. His work emphasizes evidence-based personalization of psychiatric care, including balancing efficacy, tolerability, comorbid medical risk, adherence, and patient priorities when choosing and monitoring treatment.
AI and Data Sciences Showcase:
Medlink Global
Davos of Precision Medicine
PMWC 2027 Program
January 27–29, 2027 · Santa Clara Convention Center
Swipe speakers · Tap a card for sessions →
In a few words.
PMWC is indeed The Davos of Biotech
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
